Dapsone- and nitroso dapsone-specific activation of T-cells from hypersensitive patients expressing the risk allele HLA-B*13:01.

Collapse authors list.
Zhao, Qing, Alhilali, Khetam, Alzahrani, Abdulaziz, Almutairi, Mubarak, Amjad, Juwaria, Liu, Hong, Sun, Yonghu, Sun, Lele, Zhang, Huimin, Meng, Xiaoli et al (show 7 more authors) , Gibson, Andrew, Ogese, Monday O, Park, B Kevin, Liu, Jianjun, Ostrov, David A, Zhang, Furen and Naisbitt, Dean J (2019) Dapsone- and nitroso dapsone-specific activation of T-cells from hypersensitive patients expressing the risk allele HLA-B*13:01. Allergy.

	Text manuscript text not highlighted.docx - Submitted version Download (74kB)
	Slideshow figures 1BW.ppt - Submitted version Download (631kB)
	Text figures 2BW.pdf - Submitted version Download (394kB)
	Text figures 3BW.pdf - Submitted version Download (430kB)
	Text figures 4BW.pdf - Submitted version Download (303kB)
	Text figures 5BW.pdf - Submitted version Download (363kB)
	Text figures 6BW.pdf - Submitted version Download (441kB)
	Text figures 7BW.pdf - Submitted version Download (377kB)
	Text Graphic abstract.pdf - Submitted version Download (21kB)

Abstract

BACKGROUND:Research into drug hypersensitivity associated with expression of specific HLA alleles has focussed on the interaction between parent drug and the HLA with no attention given to reactive metabolites. For this reason, we have studied HLA-B*13:01-linked dapsone hypersensitivity to (1) explore whether the parent drug and/or nitroso metabolite activates T-cells and (2) determine whether HLA-B*13:01 is involved in the response. METHODS:PBMC from 6 patients were cultured with dapsone and nitroso dapsone and proliferative responses and IFN-γ release were measured. Dapsone- and nitroso dapsone-specific T-cell clones were generated and phenotype, function, HLA allele restriction and cross-reactivity assessed. Dapsone intermediates were characterized by mass spectrometry. RESULTS:PBMC from 6 patients and cloned T-cells proliferated and secreted Th1/2/22 cytokines when stimulated with dapsone (clones: n=395; 80% CD4+ CXCR3hi CCR4hi , 20% CD8+CXCR3hi CCR4hi CCR6hi CCR9hi CCR10hi ) and nitroso dapsone (clones: n=399; 78% CD4+, 22% CD8+ with same chemokine receptor profile). CD4+ and CD8+ clones were HLA-class II and class I restricted, respectively, and displayed three patterns of reactivity: compound-specific, weakly crossreactive and strongly cross reactive. Nitroso dapsone formed dimers in culture and was reduced to dapsone, providing a rationale for the crossreactivity. T-cell responses to nitroso dapsone were dependent on the formation of a cysteine-modified protein adduct, while dapsone interacted in a labile manner with antigen presenting cells. CD8+ clones displayed an HLA-B*13:01-restricted pattern of activation. CONCLUSION:These studies describe the phenotype and function of dapsone- and nitroso dapsone-responsive CD4+ and CD8+ T-cells from hypersensitive patients. Discovery of HLA-B*13:01-restricted CD8+ T-cell responses indicates that drugs and their reactive metabolites participate in HLA allele-linked forms of hypersensitivity. This article is protected by copyright. All rights reserved.

Item Type:	Article
Depositing User:	Symplectic Admin
Date Deposited:	09 Apr 2019 08:40
Last Modified:	19 Jan 2023 00:56
DOI:	10.1111/all.13769
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3035088

Available Versions of this Item

• Dapsone- and nitroso dapsone-specific activation of T-cells from hypersensitive patients expressing the risk allele HLA-B*13:01. (deposited 09 Apr 2019 08:40) [Currently Displayed]
  • Dapsone‐ and nitroso dapsone‐specific activation of T cells from hypersensitive patients expressing the risk allele HLA‐B*13:01. (deposited 24 Apr 2019 10:23)